SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections

By the beginning of 2020, infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had rapidly evolved into an emergent worldwide pandemic, an outbreak whose unprecedented consequences highlighted many existing flaws within public healthcare systems across the world. While co...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Farhan, Cyprian (author)
مؤلفون آخرون: Sohail, Muhammad Umar (author), Abdelhafez, Ibrahim (author), Salman, Salma (author), Attique, Zakria (author), Kamareddine, Layla (author), Al-Asmakh, Maha (author)
التنسيق: article
منشور في: 2021
الموضوعات:
الوصول للمادة أونلاين:http://dx.doi.org/10.1016/j.ijid.2021.02.071
https://www.sciencedirect.com/science/article/pii/S1201971221001569
http://hdl.handle.net/10576/17970
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1857415087445245952
author Farhan, Cyprian
author2 Sohail, Muhammad Umar
Abdelhafez, Ibrahim
Salman, Salma
Attique, Zakria
Kamareddine, Layla
Al-Asmakh, Maha
author2_role author
author
author
author
author
author
author_facet Farhan, Cyprian
Sohail, Muhammad Umar
Abdelhafez, Ibrahim
Salman, Salma
Attique, Zakria
Kamareddine, Layla
Al-Asmakh, Maha
author_role author
dc.creator.none.fl_str_mv Farhan, Cyprian
Sohail, Muhammad Umar
Abdelhafez, Ibrahim
Salman, Salma
Attique, Zakria
Kamareddine, Layla
Al-Asmakh, Maha
dc.date.none.fl_str_mv 2021-03-25T06:35:51Z
2021-04-30
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://dx.doi.org/10.1016/j.ijid.2021.02.071
Cyprian F, Sohail MU, Abdelhafez I, Salman S, Attique Z, Kamareddine L, Al-Asmakh M. SARS-CoV-2-Immune-Microbiome Interaction: Lessons from Respiratory Viral Infections. Int J Infect Dis. 2021 Feb 18;105:540–50. doi: 10.1016/j.ijid.2021.02.071.
12019712
https://www.sciencedirect.com/science/article/pii/S1201971221001569
http://hdl.handle.net/10576/17970
540-550
105
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Elsevier
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv SARS-CoV-2
COVID-19
Respiratory tract microbiome
Gut microbiome
Immunity
dc.title.none.fl_str_mv SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description By the beginning of 2020, infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had rapidly evolved into an emergent worldwide pandemic, an outbreak whose unprecedented consequences highlighted many existing flaws within public healthcare systems across the world. While coronavirus disease 2019 (COVID-19) is bestowed with a broad spectrum of clinical manifestations, involving the vital organs, the respiratory system transpires as the main route of entry for SARS-CoV-2, with the lungs being its primary target. Of those infected, up to 20% require hospitalization on account of severity, while the majority of patients are either asymptomatic or exhibit mild symptoms. Exacerbation in the disease severity and complications of COVID-19 infection have been associated with multiple comorbidities, including hypertension, diabetes mellitus, cardiovascular disorders, cancer, and chronic lung disease. Interestingly, a recent body of evidence indicated the pulmonary and gut microbiomes as potential modulators for altering the course of COVID-19, potentially via the microbiome-immune system axis. While the relative concordance between microbes and immunity has yet to be fully elucidated with regards to COVID-19, we present an overview of our current understanding of COVID-19-microbiome-immune cross talk and discuss the potential contributions of microbiome-related immunity to SARS-CoV-2 pathogenesis and COVID-19 disease progression.
eu_rights_str_mv openAccess
format article
id qu_98afe97dc73e217f2f04363c8e3f9d28
identifier_str_mv Cyprian F, Sohail MU, Abdelhafez I, Salman S, Attique Z, Kamareddine L, Al-Asmakh M. SARS-CoV-2-Immune-Microbiome Interaction: Lessons from Respiratory Viral Infections. Int J Infect Dis. 2021 Feb 18;105:540–50. doi: 10.1016/j.ijid.2021.02.071.
12019712
540-550
105
language_invalid_str_mv en
network_acronym_str qu
network_name_str Qatar University repository
oai_identifier_str oai:qspace.qu.edu.qa:10576/17970
publishDate 2021
publisher.none.fl_str_mv Elsevier
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
spelling SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infectionsFarhan, CyprianSohail, Muhammad UmarAbdelhafez, IbrahimSalman, SalmaAttique, ZakriaKamareddine, LaylaAl-Asmakh, MahaSARS-CoV-2COVID-19Respiratory tract microbiomeGut microbiomeImmunityBy the beginning of 2020, infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had rapidly evolved into an emergent worldwide pandemic, an outbreak whose unprecedented consequences highlighted many existing flaws within public healthcare systems across the world. While coronavirus disease 2019 (COVID-19) is bestowed with a broad spectrum of clinical manifestations, involving the vital organs, the respiratory system transpires as the main route of entry for SARS-CoV-2, with the lungs being its primary target. Of those infected, up to 20% require hospitalization on account of severity, while the majority of patients are either asymptomatic or exhibit mild symptoms. Exacerbation in the disease severity and complications of COVID-19 infection have been associated with multiple comorbidities, including hypertension, diabetes mellitus, cardiovascular disorders, cancer, and chronic lung disease. Interestingly, a recent body of evidence indicated the pulmonary and gut microbiomes as potential modulators for altering the course of COVID-19, potentially via the microbiome-immune system axis. While the relative concordance between microbes and immunity has yet to be fully elucidated with regards to COVID-19, we present an overview of our current understanding of COVID-19-microbiome-immune cross talk and discuss the potential contributions of microbiome-related immunity to SARS-CoV-2 pathogenesis and COVID-19 disease progression.Elsevier2021-03-25T06:35:51Z2021-04-30Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://dx.doi.org/10.1016/j.ijid.2021.02.071Cyprian F, Sohail MU, Abdelhafez I, Salman S, Attique Z, Kamareddine L, Al-Asmakh M. SARS-CoV-2-Immune-Microbiome Interaction: Lessons from Respiratory Viral Infections. Int J Infect Dis. 2021 Feb 18;105:540–50. doi: 10.1016/j.ijid.2021.02.071.12019712https://www.sciencedirect.com/science/article/pii/S1201971221001569http://hdl.handle.net/10576/17970540-550105enhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:qspace.qu.edu.qa:10576/179702024-07-23T11:23:31Z
spellingShingle SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
Farhan, Cyprian
SARS-CoV-2
COVID-19
Respiratory tract microbiome
Gut microbiome
Immunity
status_str publishedVersion
title SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
title_full SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
title_fullStr SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
title_full_unstemmed SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
title_short SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
title_sort SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
topic SARS-CoV-2
COVID-19
Respiratory tract microbiome
Gut microbiome
Immunity
url http://dx.doi.org/10.1016/j.ijid.2021.02.071
https://www.sciencedirect.com/science/article/pii/S1201971221001569
http://hdl.handle.net/10576/17970